Details of the Drug

General Information of Drug (ID: DMMT5Q4)

Drug Name
Amantidine
Synonyms
adamantan-1-amine; 1-Adamantylamine; 1-Aminoadamantane; Adamantanamine; Adamantylamine; Aminoadamantane; Symmetrel; 1-Adamantanamine; 768-94-5; Amantidine; Pk-merz; Adamantamine; Symadine; 1-Adamantamine; Amantadinum; Amantadina; Amantadine [INN:BAN]; Amantadinum [INN-Latin]; Amantadina [INN-Spanish]; adamantan-1-ylamine; Gocovri; TCMDC-125869; 1-adamantaneamine; UNII-BF4C9Z1J53; 1-Aminotricyclo(3.3.1.1(sup 3,7))decane; NSC 341865; Tricyclo(3.3.1.13,7)decan-1-amine; HSDB 3202; tricyclo[3.3.1.1~3,7~]decan-1-amine; Tricyclo[3.
Indication
Disease Entry ICD 11 Status REF
Influenza virus infection 1E30-1E32 Approved [1]
Severe acute respiratory syndrome (SARS) 1D65 Investigative [2]
Affected Organisms
Humans and other mammalsVarious viruses
ATC Code
D06BB02: Amantidine
D06BB: Antivirals
D06B: CHEMOTHERAPEUTICS FOR TOPICAL USE
D06: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
D: DERMATOLOGICALS
J05AC03: Amantidine
J05AC: Cyclic amines
J05A: DIRECT ACTING ANTIVIRALS
J05: ANTIVIRALS FOR SYSTEMIC USE
J: ANTIINFECTIVES FOR SYSTEMIC USE
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C10H17N
Canonical SMILES
C1C2CC3CC1CC(C2)(C3)N
InChI
InChI=1S/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H2
InChIKey
DKNWSYNQZKUICI-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
2130
ChEBI ID
CHEMBL660
CAS Number
768-94-5
UNII
BF4C9Z1J53
DrugBank ID
DB00915
TTD ID
D09MCG
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug Pharmacogenomic Perturbation (DPP)NEW Click to Jump to the Detailed DPP Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (ANDA) 209171.
2 Coronavirus envelope protein: current knowledge. Virol J. 2019 May 27;16(1):69.